Tag: Motley Fool

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that investors might want to hear about are summarised below. Here’s why top brokers think investors ought to sell these shares next week:

Magellan Financial Group Ltd (ASX: MFG)

According to a note out of UBS, its analysts have retained their sell rating and slashed their price target on this fund manager’s shares to $17.00. This follows news that Magellan has lost its biggest client, St James Place. UBS suspects there could be more mandate terminations in the future, as well as further net fund outflows. The broker feels this will put pressure on fund fees. The Magellan share price was trading at $21.21 at Friday’s close.

Virtus Health Ltd (ASX: VRT)

A note out of Morgan Stanley reveals that its analysts have retained their underweight rating and $6.50 price target on this fertility treatment company’s shares. While the broker notes that trading conditions have been better than it was expecting this year, it isn’t enough for a change of rating. Morgan Stanley continues to see its shares as fully valued at the current level. The Virtus Health share price was fetching $6.84 at the end of the week.

Woolworths Group Ltd (ASX: WOW)

Analysts at Credit Suisse have retained their underperform rating but lifted their price target on this retail conglomerate’s shares to $31.92. This follows the release of a trading update this month which fell short of the broker’s expectations. Its underperformance and cost disruptions has led to Credit Suisse downgrading its earnings forecasts. The Woolworths share price was trading at $37.71 at the end of the week.

The post Top brokers name 3 ASX shares to sell next week appeared first on The Motley Fool Australia.

More reading

• These were the worst performing ASX 200 shares last week
• The Magellan (ASX:MFG) share price is now up 11% in 3 days. What’s going on?
• Here are the top 10 ASX shares today
• Aussie investors now hold more Tesla than Woolworths (ASX:WOW)
• Douglass speaks out: ‘We’ve never sold a single share in Magellan’

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Virtus Health Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/30WtAjo

Small cap ASX shares have the potential to deliver good growth over the long-term.

They are starting from a much smaller position, giving them more of a runway for growth over time.

Just because a business is small doesn’t automatically make it a good idea, but these two businesses are compelling options:

Doctor Care Anywhere Group PLC (ASX: DOC)

Doctor Care Anywhere is a UK-based telehealth company that is “committed to the best possible patient experience and clinical care through digitally enabled, joined up, evidence based pathways on its proprietary platform.”

It recently announced the launch of a new operating model. It’s an evolution from the provision of a single option of 20-minute virtual GP consultations to the provision of multiple options based on a patient’s clinical requirement.

There were three options that the small cap ASX share noted.

The first was a virtual GP consultation.

The second was a consultation with an advanced nurse practitioner.

Third, a “QuickConsult”, where a patient completes a questionnaire to be reviewed by a prescribing clinician, resulting in written advice or a prescription with the need for a real time video or phone consultation.

This is expected to improve access for a larger number of patients and significantly improve the margins and profitability of the company.

Doctor Care Anywhere continues to grow. In the latest quarter, for the three months to September 2021, it saw quarter on quarter revenue growth of 21.6% to £5.8 million. Consultations grew by 30.6% quarter on quarter to a total of 116,800 consultations.

Healthia Ltd (ASX: HLA)

Healthia is another small cap ASX share in the healthcare space. It offers a number of different ‘allied’ health services including podiatry, physiotherapy, hand and upper arm therapy, pilates, orthopaedic, optometry and so on.

The company is benefiting from both acquisitions and organic growth.

Indeed, just today it announced acquisitions. It’s buying LensPro Optometrists which has eight stores in south east Queensland. Healthia is also buying a physiotherapy business in Queensland as well as one in Victoria.

Those acquisitions are expected to add to annualised underlying revenue and earnings before interest, tax, depreciation and amortisation (EBITDA) by $9.5 million and $1.9 million respectively.

The total acquisitions for the six months to 31 December 2021 are projected to contribute annualised underlying revenue and EBITDA by $82.9 million and $15.9 million respectively. Total capital allocated to these acquisitions is $104.2 million.

Healthia expects to deploy a minimum of $20 million of capital per annum on new acquisitions.

COVID restrictions have impacted Healthia’s ability to trade in FY22 in some locations, but FY21 saw organic revenue growth of 9.1%. FY21 also saw underlying EBITDA growth of 62.3% year on year and underlying earnings per share (EPS) growth of 51.6%.

The post 2 small cap ASX shares for 2022 with big potential appeared first on The Motley Fool Australia.

More reading

• Why Doctor Care Anywhere (ASX:DOC) is soaring 12% today
• Why is the Doctor Care Anywhere (ASX:DOC) share price getting attention today?
• 2 fast growth ASX shares that could be buys in December 2021

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Doctor Care Anywhere Group PLC and HEALTHIA FPO. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC and HEALTHIA FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3qI4mOT

The team at Bell Potter has been running the rule over a number of ASX shares and has named its top picks for 2022.

Among its picks are the three ASX 200 shares below. Here’s why it thinks these are three of the best buys for 2022:

A2 Milk Company Ltd (ASX: A2M)

A bit of a controversial pick given its abject performance over the last 12 months, but Bell Potter believes it could be well worth sticking with this infant formula company. It currently has a buy rating and $7.70 price target on its shares.

Bell Potter explained: “We see the scope for EPS to double by FY26e, if A2M can execute on the China offline expansion strategy, while recovering 50% of the lost sales (from FY20-21) in English label IMF. The catalyst to regaining lost English label sales is likely to be boarder reopening and the return of international students. Exiting the loss making US assets or navigating a turnaround at the MVM asset would likely accelerate this turnaround. We do not see the current share price as reflecting this potential.”

Life360 Inc (ASX: 360)

In the tech sector, Bell Potter rates Life360 very highly and has a buy rating and $16.25 price target on its shares. The broker likes Life360’s freemium model and ability to convert its huge user base into paying subscribers.

Bell Potter commented: “The company has also recently announced two acquisitions – Jiobit and Tile – so that now it not only connects and protects people but also pets and things. Yes Life360 is currently not profitable but the unique positioning of the company means it is well placed to disrupt the safety and security market and so achieve strong top line growth for years to come.”

Regis Resources Limited (ASX: RRL)

In the resources sector, the broker is bullish on ASX 200 gold miner Regis Resources. It believes its shares could double over the next 12 months. Bell Potter has a buy rating and $3.81 price target on them.

Its analysts said: “RRL’s share price has continued to drift on a forecast slow start to FY22 and a lack of conviction on the gold price. However, RRL continues to be competitive with peers on operating and cost metrics and is relatively cheap on a number of valuation metrics. [..] RRL offers exposure to a long-life, low-cost asset base and the opportunity of organic growth at McPhillamys lifting group production to ~700kozpa. On a risk-reward basis, at these levels, we view RRL is a standout in the sector.”

The post Bell Potter names 3 of the best ASX 200 shares to buy in 2022 appeared first on The Motley Fool Australia.

More reading

• These were the worst performing ASX 200 shares last week
• These were the best performing ASX 200 shares last week
• 3 fantastic ASX shares to buy for Christmas
• Here are the top 10 ASX shares today
• The ASX share market coverage that captivated readers in 2021

Motley Fool contributor James Mickleboro owns Life360, Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Life360, Inc. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3yVK9sv

It was a good five days for the S&P/ASX 200 Index (ASX: XJO) last week. The benchmark index rose 1.4% over the period to end at 7,420.3 points.

Unfortunately, not all shares climbed higher with the market. Here’s why these were the worst performing ASX 200 shares last week:

Magellan Financial Group Ltd (ASX: MFG)

The Magellan share price was the worst performer on the ASX 200 last week with a 27.8% decline. Investors were selling off the fund manager’s shares after it announced the termination of the St James’s Place mandate. The release notes that the mandate represents approximately 12% of the company’s current annual revenues. As a result, the termination of the mandate at this point in the financial year is anticipated to impact its FY 2022 revenues by 6%. Investors appear concerned more mandates could be lost, particularly given the abject performance of its flagship fund.

CIMIC Group Ltd (ASX: CIM)

The CIMIC share price was some way behind as the next worst performer with a 9% decline. This was despite the mining, construction and engineering services company announcing a $1.8 billion New South Wales government contract win for its subsidiary CPB Contractors. It is unclear what sparked the selling.

Bega Cheese Ltd (ASX: BGA)

The Bega share price was out of form and dropped 8.1% over the five days. Investors were selling the diversified food company’s shares after the release of underwhelming FY 2022 guidance. Bega provided guidance for normalised EBITDA in the range of $195 million to $215 million. While this will be an increase of 37% to 51% year on year, it was short of the market’s expectations. The Bloomberg consensus estimate was $222 million.

Charter Hall Group (ASX: CHC)

The Charter Hall share price wasn’t far behind with a 7% decline. This follows news that the property company is acquiring a 50% interest in Paradice Investment Management (PIM). Charter Hall advised that it will pay $207 million for the stake. This comprises 70% in shares and 30% in cash. PIM is a fund manager with around $18.2 billion in funds under management. It appears as though some investors are keen on the move.

The post These were the worst performing ASX 200 shares last week appeared first on The Motley Fool Australia.

More reading

• These were the best performing ASX 200 shares last week
• Here are the top 10 ASX shares today
• The Magellan (ASX:MFG) share price is now up 11% in 3 days. What’s going on?
• The ASX share market coverage that captivated readers in 2021
• ASX 200 (ASX:XJO) midday update: AMP shoots higher, travel shares rise

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3sxBnQ5

Are you looking to make some additions to your portfolio in 2022? If you are, the three ASX shares listed below could be great options.

They have been tipped as shares that could generate strong returns for investors in the future. Here’s why they could be five-star stocks:

CSL Limited (ASX: CSL)

The first five-star stock for investors in 2022 is CSL. It is one of the world’s leading biotherapeutics companies with a portfolio of life-saving, world class therapies and vaccines. Its products are used around the world to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological disorders. The company is also in the process of adding treatments for iron deficiency, nephrology and cardio-renal to its arsenal through the acquisition of Vifor Pharma for $17 billion. Together with its ~US$1 billion annual spend on R&D, CSL looks well-placed for growth over the long term.

Citi currently has a buy rating and $340.00 price target on the company’s shares.

Domino’s Pizza Enterprises Ltd (ASX: DMP)

Another five-star stock to look at is Domino’s. This pizza chain operator could be a quality option for investors due to its bold growth plans and the ongoing popularity of its offering. In respect to its growth plans, management is aiming to more than double its footprint to 6,650 stores in existing markets by 2033. It also has the balance sheet strength to make acquisitions that increase its addressable market even further. Combined with its long track record of delivering solid same store sales growth, this bodes well for its growth over the 2020s.

Goldman Sachs is a fan of the company and has a buy rating and $147.00 price target on its shares.

REA Group Limited (ASX: REA)

A final five-star stock to consider buying in 2022 is REA Group. It is the digital advertising company that operates Australia’s leading property website, realestate.com.au. In addition, REA operates a number of complementary businesses in the Australian market and internationally. This includes its growing presence in the mortgage broker market following the acquisition of Mortgage Choice. All in all, together with new revenue streams, its good cost control, and a booming housing market, REA Group appears well-placed for growth.

Macquarie is very positive on the company’s outlook and has an outperform rating and $192.00 price target on its shares.

The post 3 five-star ASX shares to buy in 2022 appeared first on The Motley Fool Australia.

More reading

• Where are CSL (ASX:CSL) shares headed in 2022?
• Do these two unloved ASX shares offer tasty returns?
• 2 high quality ASX 200 shares with huge upside potential
• Here are the top 10 ASX shares today
• Interested in the $750m CSL (ASX:CSL) share purchase plan? Here are the details

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited and REA Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3FwZUIL

The S&P/ASX 200 Index (ASX: XJO) was on form last week and stormed higher over the five days. The benchmark index rose 1.4% over the period to end at 7,420.3 points.

While a good number of shares climbed higher with the market, some rose more than most. Here’s why these were the best performing ASX 200 shares last week:

Link Administration Holdings Ltd (ASX: LNK)

The Link share price was the best performer on the ASX 200 last week with a 12.9% gain. Investors were buying the administration services company’s shares after it received a takeover approach from Dye & Durham. If the deal goes ahead, Link shareholders will receive $5.50 per share in cash and a 3 cents per share interim dividend.

Mineral Resources Limited (ASX: MIN)

The Mineral Resources share price wasn’t far behind with a gain of 11.1% over the five days. This appears to have been driven by a broker note out of Macquarie. Last week the broker held firm with its outperform rating and lifted its price target by 10% to a lofty $79.00. Macquarie believes that Mineral Resources is well-positioned to benefit from record lithium prices for the next four years.

PolyNovo Ltd (ASX: PNV)

The PolyNovo share price was on form again and charged 10.7% over the period. Investors have been buying the medical device company’s shares since the release of a strong second quarter update last week. That update revealed that sales for October and November in the United States are up 133% over the prior corresponding period to $4.66 million.

AMP Ltd (ASX: AMP)

The AMP share price was a strong performer and climbed 10.5% last week. A good portion of this gain was made on Friday after it announced a divestment from its private markets business, PrivateMarketsCo. AMP has agreed to sell its infrastructure debt platform to Ares Holdings for a total cash consideration of $428 million. The agreement follows PrivateMarketsCo’s strategic decision to focus on managing equity investments in real estate and infrastructure.

The post These were the best performing ASX 200 shares last week appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX shares today
• The ASX share market coverage that captivated readers in 2021
• Why AMP, Hipages, Pilbara Minerals, and Webjet shares are storming higher
• ASX 200 (ASX:XJO) midday update: AMP shoots higher, travel shares rise
• Here’s why the AMP (ASX:AMP) share price is racing 6% higher today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Link Administration Holdings Ltd and POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3yYvqg8

Listed below are two ASX dividend shares that have been tipped to provide attractive yields for investors in the coming years.

Here’s why analysts think these dividend shares are in the buy zone:

Accent Group Ltd (ASX: AX1)

The first ASX dividend share to look at is Accent. It is the retailer behind a growing network of footwear focused brands.

Thanks to the popularity of these brands and its exclusive licensing agreements, Accent has been growing its earnings and dividends at a consistently solid rate for many years. Pleasingly, the company looks well-placed to continue this positive trend over the 2020s. Particularly given its expansion opportunities.

Bell Potter is a big fan of Accent. It currently has a buy rating and $3.05 price target on its shares.

The broker is also forecasting fully franked dividends per share of 9.1 cents in FY 2022 and then 13.5 cents in FY 2023. Based on the latest Accent share price of $2.38, this represents yields of 3.8% and 5.6%, respectively.

South32 Ltd (ASX: S32)

Another ASX dividend share to look at is this mining giant. It could be a top option for income investors due to its attractive valuation and strong free cash flow generation.

The latter is being underpinned by its exposure to a number of in-demand commodities such as aluminium. Furthermore, South32 has recently announced the addition of copper to its portfolio via a key earnings accretive acquisition in Chile.

All in all, the team at Goldman Sachs believe this will allow South32’s shares to provide investors with big fully franked dividend yields in the coming years. In fact, based on the latest South32 share price of $4.01, Goldman expects yields greater than 10% per annum for the next five years.

Goldman has a conviction buy rating and $4.40 price target on its shares.

The post 2 quality ASX dividend shares to buy appeared first on The Motley Fool Australia.

More reading

• 3 ASX 200 dividend shares to buy for 2022 and beyond
• What are experts saying to expect for the South32 (ASX:S32) share price in 2022?
• 2 cheap ASX dividend shares with big yields
• Analysts say buy these ASX dividend shares
• These 3 ASX 200 shares are topping the volume charts on Monday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3sti36F

There are a large number of ASX shares to choose from on the Australian share market.

Three that come highly rated are listed below. Here’s why these ASX shares are being tipped as buys:

Healius Ltd (ASX: HLS)

The first ASX share to look at is Healius. It is one of Australia’s largest pathology and diagnostic imaging providers. This makes it extremely well-placed to benefit greatly from increasingly strong demand for COVID-19 testing. This certainly was the case in the first quarter when Healius reported a 43.7% increase in quarterly revenue over the prior corresponding period to $689.9 million. More of the same is expected over the remainder of FY 2022.

Earlier this week, Morgans upgraded the company’s shares to an add rating with a $5.79 price target.

Life360 Inc (ASX: 360)

Another share to look at is Life360. Through its eponymous Life360 app, the company operates in the digital consumer subscription services market. It has a focus on products and services for digitally native families, where all members of the household are connected by smartphones. At the last count, the company had a massive 33.8 million monthly active users are using its app. This is supporting stellar recurring revenue growth and provides it with countless opportunities to monetise its user base further in the future.

Bell Potter is bullish on Life360. It currently has a buy rating and $16.25 price target on its shares.

SEEK Limited (ASX: SEK)

A final ASX share to consider is this job listings company. While SEEK was hit hard by the pandemic, it bounced back very strongly in FY 2021. It reported a 1% increase in revenue to $1,591 million and a 58% jump in net profit after tax (excluding significant items) to $141 million. The good news is that more of the same is expected in the coming years as the Australian economy recovers from COVID-19.

Credit Suisse is a fan of SEEK and has an outperform rating and $39.50 price target on its shares.

The post 3 fantastic ASX shares to buy for Christmas appeared first on The Motley Fool Australia.

More reading

• 2 exciting ASX 200 tech shares to buy
• Healius (ASX:HLS) share price higher despite analysts questioning acquisition value
• 2 value ASX shares ready for a big 2022: fund manager
• 2 ASX shares to buy and hold for 10 years+
• 2 fantastic blue chip ASX 200 shares to buy next week

Motley Fool contributor James Mickleboro owns Life360, Inc. and SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Life360, Inc. The Motley Fool Australia has recommended SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3H6sBg4

The Zip Co Ltd (ASX: Z1P) share price has spent this Christmas Eve enjoying a pretty solid day of trading on the ASX.

Zip shares closed the day at $4.39 each, up 0.23% for the day. (The ASX closed early at 2pm today for Christmas.)

But zooming out and the picture isn’t quite as… zippy (apologies). Zip shares are down a nasty 21% year to date. And wait for this one… they’re also down 70% from their all-time high of $14.53 that we saw back in February.

But now that 2021 is almost behind us, what does 2022 hold in store for this buy now, pay later (BNPL) heavyweight?

What to watch for Zip shares in 2022

Well, we of course can’t be certain, although my Fool colleague Tristan recently went through what some expert ASX investors think might happen with the Zip share price in 2022.

But let’s look at some important dates that Zip shareholders might want to proverbially note in their 2022 diaries.

First up, Zip’s annual general meeting (AGM) is scheduled to be held on 3 November. So circle that in the old calendar.

Another event investors should watch out for is the completion of Zip’s Twisto acquisition. Zip told ASX investors that it is buying the Europe-based Twisto payments company last month. It will be shelling out $115.8 million for it.

The company is hoping this acquisition will help Zip crack the lucrative European market. But Zip says the transaction will only be finalised in “the second quarter” of the company’s 2022 financial year.

Finally, unlike some ASX companies, Zip hasn’t yet given us its reporting dates for 2022.

So, that’s about all we know that’s set in stone for Zip announcements next year.

Zip CEO Larry Diamond recently said that Zip is entering 2022 “with strong momentum, in a solid financial position, with a continued focus on execution, unit economics and global synergies”. So that’s a pretty good start if all goes well.

At the current Zip share price, this BNPL share has a market capitalisation of $2.6 billion.

The post Own Zip (ASX:Z1P) shares? Here are some key dates to watch in 2022 appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX shares today
• Why is the Zip (ASX:Z1P) share price outperforming Afterpay today?
• Why has the short interest in Zip (ASX:Z1P) shares fallen in December?
• These are the 10 most shorted ASX shares
• These were the worst performers on the ASX 200 last week

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended ZIPCOLTD FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3Hcq1F9

The Lithium Australia NL (ASX: LIT) share price finished in the green this week.

The lithium company’s shares were swapping hands for 11.5 cents apiece at Friday’s close, up 4.55% on the day. That means its shares have gained 9.5% from last Friday’s closing price of 10.5 cents.

Let’s take a look at what’s been happening at the company lately.

What’s going on with Lithium Australia?

The Lithium Australia share price is climbing despite no price-sensitive news being released to the market. However, the company has made several announcements this week.

The lithium market is also gaining significant global interest and is seen by investors as a booming industry

Early this afternoon, the company issued 1.5 million shares to the market at 5.5 cents each. This raised $82,500 to exercise options held by Lind Global Macro Fund. This may explain the share price drop in the afternoon — it fell from a high of 12 cents — since issuing more shares to the market dilutes the value of each individual share.

On Tuesday, the company advised it is advancing its lithium extraction technology towards commercialisation.

The company is working with the Australian Nuclear Science and Technology Organisation to develop technology known as LieNA. This process can refine low-grade spodumene, which is used to produce high-purity lithium phosphate. Lithium Australia is working towards a patent on this technology.

Meanwhile, on Wednesday, Lithium Australia advised its battery recycling division has expanded to a bigger site in Laverton, Victoria. The company’s subsidiary has been granted a permit from the local council.

Lithium Australian managing director Adrian Griffin said:

Capturing larger volumes of spent lithium-ion batteries in particular helps the company create a secure battery supply chain, further underpinning the investment of Lithium Australia shareholders.

Lithium Australia share price recap

The Lithium Australia share price has charged ahead this year, up around 70% since the start of 2021.

Despite this, the company’s shares have shed 10% in the past month but are up 2% this week.

The company has a market capitalisation of nearly $116 million based on the current share price.

The post Here’s whats happening to the Lithium Australia share price this week (ASX:LIT) appeared first on The Motley Fool Australia.

More reading

• Own Zip (ASX:Z1P) shares? Here are some key dates to watch in 2022
• Here are the top 10 ASX shares today
• Early Christmas: Ark Mines (ASX:AHK) share price makes a comeback
• Why is the IAG (ASX:IAG) share price underperforming QBE in 2021?
• Tesserent (ASX:TNT) share price pops by 6% amid acquisitions update

from The Motley Fool Australia https://ift.tt/32fuzvX